Michael Salomon
Corporate Officer/Principal bei SIRION Biotech GmbH
Profil
Michael Salomon is currently the Senior Vice President-Development at SIRION Biotech GmbH since 2007.
Prior to this, he worked as the Leader-Research Group at Ludwig-Maximilians-Universität München and as the Head-Research & Development at Vertis Biotechnologie AG.
He obtained his doctorate degree from Ludwig-Maximilians-Universität München in 1991.
Aktive Positionen von Michael Salomon
Unternehmen | Position | Beginn |
---|---|---|
SIRION Biotech GmbH
SIRION Biotech GmbH Miscellaneous Commercial ServicesCommercial Services SIRION BIOTECH GmbH operates cell modeling and viral vector platforms. The firm offers gene knockdown cells, cell line development, RNA validation services, AV cloning and purification, transduction enhancer and premade adenovirus. The company was founded by Lars Behrend and Christian Thirion in 2006 and is headquartered in Martinsried, Germany. | Corporate Officer/Principal | 01.09.2007 |
Ehemalige bekannte Positionen von Michael Salomon
Unternehmen | Position | Ende |
---|---|---|
Vertis Biotechnologie AG | Technik-/Wissenschafts-/F&E-Leiter | - |
Ludwig-Maximilians-Universität München | Corporate Officer/Principal | - |
Ausbildung von Michael Salomon
Ludwig-Maximilians-Universität München | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
SIRION Biotech GmbH
SIRION Biotech GmbH Miscellaneous Commercial ServicesCommercial Services SIRION BIOTECH GmbH operates cell modeling and viral vector platforms. The firm offers gene knockdown cells, cell line development, RNA validation services, AV cloning and purification, transduction enhancer and premade adenovirus. The company was founded by Lars Behrend and Christian Thirion in 2006 and is headquartered in Martinsried, Germany. | Commercial Services |
Vertis Biotechnologie AG |